生物活性 | |||
---|---|---|---|
描述 | Eniluracil, also known as 5-Ethynyluracil, is an orally active dihydropyrimidine dehydrogenase (DPD) inhibitor. Eniluracil irreversibly inhibits DPD, increases the oral bioavailability of 5-fluorouracil to 100% and promotes the homogeneous absorption and toxicity of 5-fluorouracil. Eniluracil can be used in combination with fluoropyrimidines (e.g., 5-fluorouracil) in combination for cancer research[1][2].Eniluracil contains an alkyne group that can undergo copper-catalysed azide-alkyne cycloaddition (CuAAc) with molecules containing an azide moiety, and can therefore be used as a click chemistry reagent. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
7.35mL 1.47mL 0.73mL |
36.74mL 7.35mL 3.67mL |
73.47mL 14.69mL 7.35mL |
参考文献 |
---|